Pets: is it ethical to keep them?
Apr 27, 2019 06:10 am UTC| Insights & Views
According to the UK veterinary charity The Peoples Dispensary for Sick Animals (PDSA), half of Britons own a pet. Many of these owners view the 11.1m cats, 8.9m dogs, and 1m rabbits sharing their homes as family members....
Either Jokowi or Prabowo: Indonesia's foreign policy to remain the same under new president
Apr 27, 2019 06:09 am UTC| Insights & Views
The Indonesian public still needs to wait until May 22 to know the official tally of votes in the presidential election last week. But at least five credible survey agencies are forecasting the re-election of Joko Jokowi...
Parkinson's: four unusual signs you may be at risk
Apr 27, 2019 06:09 am UTC| Insights & Views Health
Do you move around a lot during your sleep? Or have you lost your sense of smell? New insights into Parkinsons disease suggest that these might be the early signs of changes in the brain that mean you are at greater risk...
How did the moon end up where it is?
Apr 27, 2019 06:09 am UTC| Insights & Views Science
Nearly 50 years since man first walked on the moon, the human race is once more pushing forward with attempts to land on the Earths satellite. This year alone, China has landed a robotic spacecraft on the far side of the...
Trump accuses the UK of spying again – but intelligence agencies have learnt to ignore him
Apr 27, 2019 06:09 am UTC| Insights & Views Politics
Donald Trump has repeated unverified claims that Britains intelligence agencies spied on his 2016 presidential campaign, a day after Buckingham Palace confirmed he would make a three-day state visit to the UK in...
How your employer uses perks like wellness programs, phones and free food to control your life
Apr 27, 2019 06:08 am UTC| Insights & Views Health
Companies offer all sorts of benefits and extras to attract the most favored workers, from health care and stock options to free food. But all those perks come at a price: your freedom. Theres a reason labor historians...
No cure for Alzheimer's disease in my lifetime
Apr 27, 2019 06:08 am UTC| Insights & Views Health
Biogen recently announced that it was abandoning its late stage drug for Alzheimers, aducanumab, causing investors to lose billions of dollars. They should not have been surprised. Not only have there been more than...